Table 1 Clinical characteristics of the study subjects at the study baseline

From: Differences in longitudinal associations of cardiovascular risk factors with arterial stiffness and pressure wave reflection in middle-aged Japanese men

Parameter

Start

End

P value

Number

4016

4016

 

Age (years)

43 ± 9

49 ± 10

<0.01

BMI (kg/m2)

24.0 ± 3.1

24.2 ± 3.2

<0.01

Current smokers (number [%])

1269 (31.6)

1004 (25.0)

<0.01

SBP (mmHg)

124 ± 14

123 ± 15

0.22

MBP (mmHg)

91 ± 11

91 ± 12

0.87

DBP (mmHg)

75 ± 11

76 ± 11

0.29

PP (mmHg)

48 ± 9

47 ± 8

<0.01

HR (bpm)

65 ± 9

64 ± 10

<0.01

baPWV (cm/s)

1289 ± 187

1342 ± 215

<0.01

radial AI

70 ± 13

72 ± 13

<0.01

LDL (mmol/L)

3.25 ± 0.79

3.20 ± 0.77

<0.01

HDL (mmol/L)

1.61 ± 0.41

1.58 ± 0.40

<0.01

TG (mmol/L)

1.41 ± 0.99

1.37 ± 0.94

<0.01

HbA1c (%)

5.3 ± 0.6

5.5 ± 0.7

<0.01

UA (mmol/L)

369 ± 74

358 ± 72

<0.01

eGFR (ml/min/1.73 m2)

85 ± 9

82 ± 9

<0.01

Medication

  For hypertension

305 (7.6)

614 (15.3)

<0.01

  For dyslipidemia

108 (2.7)

285 (7.1)

<0.01

  For diabetes mellitus

96 (2.4)

173 (4.3)

<0.01

  For hyperuricemia

186 (4.6)

245 (6.1)

<0.01

  1. Start at the start of the observation period, End at the end of the observation period, BMI body mass index, SBP systolic blood pressure, MBP mean blood pressure, DBP diastolic blood pressure, PP pulse pressure, HR heart rate (represented as rounded down), baPWV brachial–ankle pulse wave velocity, rAI radial augmentation index, LDL serum low-density lipoprotein cholesterol level, HDL serum high-density lipoprotein cholesterol level, TG serum triglyceride level, HbA1c serum level of glycosylated haemoglobin A1c, UA serum uric acid, eGFR estimated glomerular filtration rate calculated by the Chronic Kidney Disease Epidemiology Collaboration equation, Medication number (percentage) of subjects receiving medications